Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Debio 4228 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on Debio 4228, a putative extended release formulation of a gonadotropin-releasing hormone antagonist (Jun 2024). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Debio 4228 | Debio-4228 | Hormone Antineoplastics 2 | Limited information is currently available on Debio 4228, a putative extended release formulation of a gonadotropin-releasing hormone antagonist (Jun 2024). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06395753 | Phase II | Debio 4228 | A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer | Recruiting | USA | FRA | ESP | BEL | 0 |